 | • レポートコード：QY2108PAL8902 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける腫瘍溶解性ウイルスの市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、腫瘍溶解性ウイルスの種類別市場規模（イムリジック、オンコリン、その他）、用途別市場規模（黒色腫、その他）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の腫瘍溶解性ウイルス市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における腫瘍溶解性ウイルスの種類別市場規模（2016年-2027年）：イムリジック、オンコリン、その他 ・世界における腫瘍溶解性ウイルスの用途別市場規模（2016年-2027年）：黒色腫、その他 ・腫瘍溶解性ウイルスの中国市場分析 - 腫瘍溶解性ウイルスの中国市場規模（2016年-2027年） - 中国における腫瘍溶解性ウイルスの主要プレイヤー別市場シェア - 中国における腫瘍溶解性ウイルスの種類別市場規模：イムリジック、オンコリン、その他 - 中国における腫瘍溶解性ウイルスの用途別市場規模：黒色腫、その他 ・腫瘍溶解性ウイルスの北米市場（2016年-2027年） ・腫瘍溶解性ウイルスのヨーロッパ市場（2016年-2027年） ・腫瘍溶解性ウイルスのアジア太平洋市場（2016年-2027年） ・腫瘍溶解性ウイルスの中南米市場（2016年-2027年） ・腫瘍溶解性ウイルスの中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：Amgen、Shanghai Sunway Biotech ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.
Market Analysis and Insights: Global and China Oncolytic Virus Market
This report focuses on global and China Oncolytic Virus market.
In 2020, the global Oncolytic Virus market size was US$ 16 million and it is expected to reach US$ 26 million by the end of 2027, with a CAGR of 6.8% during 2021-2027. In China the Oncolytic Virus market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Oncolytic Virus Scope and Market Size
Oncolytic Virus market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Oncolytic Virus market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Oncolytic Virus market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Imlygic
Oncorine
Others
Imlygic is the most widely used type which takes up about 85% of the total market share in 2019.
Segment by Application
Melanoma
Other Cancers
The application of oncolytic virus therapy includes melanoma and other cancer, and the proportion of sales for melanoma in 2018 is about 85.52%.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Amgen
Shanghai Sunway Biotech
1 Study Coverage
1.1 Oncolytic Virus Product Introduction
1.2 Market by Type
1.2.1 Global Oncolytic Virus Market Size Growth Rate by Type
1.2.2 Imlygic
1.2.3 Oncorine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Oncolytic Virus Market Size Growth Rate by Application
1.3.2 Melanoma
1.3.3 Other Cancers
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Oncolytic Virus Market Size, Estimates and Forecasts
2.1.1 Global Oncolytic Virus Revenue 2016-2027
2.1.2 Global Oncolytic Virus Sales 2016-2027
2.2 Global Oncolytic Virus, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Oncolytic Virus Historical Market Size by Region (2016-2021)
2.3.1 Global Oncolytic Virus Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Oncolytic Virus Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Oncolytic Virus Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Oncolytic Virus Sales Forecast by Region (2022-2027)
2.4.2 Global Oncolytic Virus Revenue Forecast by Region (2022-2027)
3 Global Oncolytic Virus Competitor Landscape by Players
3.1 Global Top Oncolytic Virus Manufacturers by Sales
3.1.1 Global Oncolytic Virus Sales by Manufacturer (2016-2021)
3.1.2 Global Oncolytic Virus Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Oncolytic Virus Manufacturers by Revenue
3.2.1 Key Oncolytic Virus Manufacturers Covered: Ranking by Revenue
3.2.2 Global Oncolytic Virus Revenue by Manufacturers (2016-2021)
3.2.3 Global Oncolytic Virus Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Oncolytic Virus Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Oncolytic Virus Revenue in 2020
3.2.6 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Oncolytic Virus Price by Manufacturers
3.4 Global Oncolytic Virus Manufacturing Base Distribution, Product Types
3.4.1 Oncolytic Virus Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Oncolytic Virus Product Type
3.4.3 Date of International Manufacturers Enter into Oncolytic Virus Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Oncolytic Virus Market Size by Type (2016-2021)
4.1.1 Global Oncolytic Virus Sales by Type (2016-2021)
4.1.2 Global Oncolytic Virus Revenue by Type (2016-2021)
4.1.3 Oncolytic Virus Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Oncolytic Virus Market Size Forecast by Type (2022-2027)
4.2.1 Global Oncolytic Virus Sales Forecast by Type (2022-2027)
4.2.2 Global Oncolytic Virus Revenue Forecast by Type (2022-2027)
4.2.3 Oncolytic Virus Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Oncolytic Virus Market Size by Application (2016-2021)
5.1.1 Global Oncolytic Virus Sales by Application (2016-2021)
5.1.2 Global Oncolytic Virus Revenue by Application (2016-2021)
5.1.3 Oncolytic Virus Price by Application (2016-2021)
5.2 Oncolytic Virus Market Size Forecast by Application (2022-2027)
5.2.1 Global Oncolytic Virus Sales Forecast by Application (2022-2027)
5.2.2 Global Oncolytic Virus Revenue Forecast by Application (2022-2027)
5.2.3 Global Oncolytic Virus Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Oncolytic Virus Market Size YoY Growth 2016-2027
6.1.1 China Oncolytic Virus Sales YoY Growth 2016-2027
6.1.2 China Oncolytic Virus Revenue YoY Growth 2016-2027
6.1.3 China Oncolytic Virus Market Share in Global Market 2016-2027
6.2 China Oncolytic Virus Market Size by Players (International and Local Players)
6.2.1 China Top Oncolytic Virus Players by Sales (2016-2021)
6.2.2 China Top Oncolytic Virus Players by Revenue (2016-2021)
6.3 China Oncolytic Virus Historic Market Review by Type (2016-2021)
6.3.1 China Oncolytic Virus Sales Market Share by Type (2016-2021)
6.3.2 China Oncolytic Virus Revenue Market Share by Type (2016-2021)
6.3.3 China Oncolytic Virus Price by Type (2016-2021)
6.4 China Oncolytic Virus Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Oncolytic Virus Sales Forecast by Type (2022-2027)
6.4.2 China Oncolytic Virus Revenue Forecast by Type (2022-2027)
6.4.3 China Oncolytic Virus Price Forecast by Type (2022-2027)
6.5 China Oncolytic Virus Historic Market Review by Application (2016-2021)
6.5.1 China Oncolytic Virus Sales Market Share by Application (2016-2021)
6.5.2 China Oncolytic Virus Revenue Market Share by Application (2016-2021)
6.5.3 China Oncolytic Virus Price by Application (2016-2021)
6.6 China Oncolytic Virus Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Oncolytic Virus Sales Forecast by Application (2022-2027)
6.6.2 China Oncolytic Virus Revenue Forecast by Application (2022-2027)
6.6.3 China Oncolytic Virus Price Forecast by Application (2022-2027)
7 North America
7.1 North America Oncolytic Virus Market Size YoY Growth 2016-2027
7.2 North America Oncolytic Virus Market Facts & Figures by Country
7.2.1 North America Oncolytic Virus Sales by Country (2016-2021)
7.2.2 North America Oncolytic Virus Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Oncolytic Virus Market Size YoY Growth 2016-2027
8.2 Asia Pacific Oncolytic Virus Market Facts & Figures by Region
8.2.1 Asia Pacific Oncolytic Virus Sales by Region (2016-2021)
8.2.2 Asia Pacific Oncolytic Virus Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Oncolytic Virus Market Size YoY Growth 2016-2027
9.2 Europe Oncolytic Virus Market Facts & Figures by Country
9.2.1 Europe Oncolytic Virus Sales by Country (2016-2021)
9.2.2 Europe Oncolytic Virus Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Oncolytic Virus Market Size YoY Growth 2016-2027
10.2 Latin America Oncolytic Virus Market Facts & Figures by Country
10.2.1 Latin America Oncolytic Virus Sales by Country (2016-2021)
10.2.2 Latin America Oncolytic Virus Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Oncolytic Virus Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country
11.2.1 Middle East and Africa Oncolytic Virus Sales by Country (2016-2021)
11.2.2 Middle East and Africa Oncolytic Virus Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Amgen
12.1.1 Amgen Corporation Information
12.1.2 Amgen Description and Business Overview
12.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Amgen Oncolytic Virus Products Offered
12.1.5 Amgen Recent Development
12.2 Shanghai Sunway Biotech
12.2.1 Shanghai Sunway Biotech Corporation Information
12.2.2 Shanghai Sunway Biotech Description and Business Overview
12.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Shanghai Sunway Biotech Oncolytic Virus Products Offered
12.2.5 Shanghai Sunway Biotech Recent Development
12.11 Amgen
12.11.1 Amgen Corporation Information
12.11.2 Amgen Description and Business Overview
12.11.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Amgen Oncolytic Virus Products Offered
12.11.5 Amgen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Oncolytic Virus Industry Trends
13.2 Oncolytic Virus Market Drivers
13.3 Oncolytic Virus Market Challenges
13.4 Oncolytic Virus Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Oncolytic Virus Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Oncolytic Virus Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Imlygic
Table 3. Major Manufacturers of Oncorine
Table 4. Major Manufacturers of Others
Table 5. Global Oncolytic Virus Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Oncolytic Virus Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Oncolytic Virus Sales by Regions (2016-2021) & (K Units)
Table 8. Global Oncolytic Virus Sales Market Share by Regions (2016-2021)
Table 9. Global Oncolytic Virus Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Oncolytic Virus Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Oncolytic Virus Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Oncolytic Virus Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Oncolytic Virus Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Oncolytic Virus Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Oncolytic Virus Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Oncolytic Virus Manufacturers by Revenue (US$ Million) in 2020
Table 17. Oncolytic Virus Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Oncolytic Virus Revenue Share by Manufacturers (2016-2021)
Table 19. Global Oncolytic Virus Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Oncolytic Virus by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus as of 2020)
Table 21. Key Manufacturers Oncolytic Virus Price (2016-2021) (US$/Unit)
Table 22. Oncolytic Virus Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Oncolytic Virus Product Type
Table 24. Date of International Manufacturers Enter into Oncolytic Virus Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Oncolytic Virus Sales by Type (2016-2021) (K Units)
Table 27. Global Oncolytic Virus Sales Share by Type (2016-2021)
Table 28. Global Oncolytic Virus Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Oncolytic Virus Revenue Share by Type (2016-2021)
Table 30. Oncolytic Virus Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Oncolytic Virus Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Oncolytic Virus Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Oncolytic Virus Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Oncolytic Virus Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Oncolytic Virus Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Oncolytic Virus Sales by Application (2016-2021) (K Units)
Table 37. Global Oncolytic Virus Sales Share by Application (2016-2021)
Table 38. Global Oncolytic Virus Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Oncolytic Virus Revenue Share by Application (2016-2021)
Table 40. Oncolytic Virus Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Oncolytic Virus Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Oncolytic Virus Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Oncolytic Virus Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Oncolytic Virus Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Oncolytic Virus Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Oncolytic Virus Sales (K Units) of Key Companies (2016-2021)
Table 47. China Oncolytic Virus Sales Share by Company (2016-2021)
Table 48. China Oncolytic Virus Revenue (US$ Million) by Company (2016-2021)
Table 49. China Oncolytic Virus Revenue Share by Company (2016-2021)
Table 50. China Oncolytic Virus Sales (K Units) by Type (2016-2021)
Table 51. China Oncolytic Virus Sales Share by Type (2016-2021)
Table 52. China Oncolytic Virus Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Oncolytic Virus Price (US$/Unit) by Type (2016-2021)
Table 54. China Oncolytic Virus Sales (K Units) by Type (2022-2027)
Table 55. China Oncolytic Virus Sales Share by Type (2022-2027)
Table 56. China Oncolytic Virus Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Oncolytic Virus Revenue Share by Type (2022-2027)
Table 58. China Oncolytic Virus Price (US$/Unit) by Type (2022-2027)
Table 59. China Oncolytic Virus Sales (K Units) by Application (2016-2021)
Table 60. China Oncolytic Virus Sales Share by Application (2016-2021)
Table 61. China Oncolytic Virus Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Oncolytic Virus Price (US$/Unit) by Application (2016-2021)
Table 63. China Oncolytic Virus Sales (K Units) by Application (2022-2027)
Table 64. China Oncolytic Virus Sales Share by Application (2022-2027)
Table 65. China Oncolytic Virus Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Oncolytic Virus Revenue Share by Application (2022-2027)
Table 67. China Oncolytic Virus Price (US$/Unit) by Application (2022-2027)
Table 68. North America Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 69. North America Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 70. North America Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Oncolytic Virus Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Oncolytic Virus Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Oncolytic Virus Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Oncolytic Virus Revenue Market Share by Region (2016-2021)
Table 76. Europe Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 77. Europe Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 78. Europe Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 80. Latin America Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Oncolytic Virus Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Oncolytic Virus Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Oncolytic Virus Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Oncolytic Virus Revenue Market Share by Country (2016-2021)
Table 88. Amgen Corporation Information
Table 89. Amgen Description and Business Overview
Table 90. Amgen Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Amgen Oncolytic Virus Product
Table 92. Amgen Recent Development
Table 93. Shanghai Sunway Biotech Corporation Information
Table 94. Shanghai Sunway Biotech Description and Business Overview
Table 95. Shanghai Sunway Biotech Oncolytic Virus Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Shanghai Sunway Biotech Product
Table 97. Shanghai Sunway Biotech Recent Development
Table 98. Oncolytic Virus Market Trends
Table 99. Oncolytic Virus Market Drivers
Table 100. Oncolytic Virus Market Challenges
Table 101. Oncolytic Virus Market Restraints
Table 102. Oncolytic Virus Customers List
Table 103. Oncolytic Virus Distributors List
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Oncolytic Virus Product Picture
Figure 2. Global Oncolytic Virus Sales Market Share by Type in 2020 & 2027
Figure 3. Imlygic Product Picture
Figure 4. Oncorine Product Picture
Figure 5. Others Product Picture
Figure 6. Global Oncolytic Virus Sales Market Share by Application in 2020 & 2027
Figure 7. Melanoma
Figure 8. Other Cancers
Figure 9. Oncolytic Virus Report Years Considered
Figure 10. Global Oncolytic Virus Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oncolytic Virus Market Size 2016-2027 (US$ Million)
Figure 12. Global Oncolytic Virus Sales 2016-2027 (K Units)
Figure 13. Global Oncolytic Virus Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Oncolytic Virus Sales Market Share by Region (2016-2021)
Figure 15. Global Oncolytic Virus Sales Market Share by Region in 2020
Figure 16. Global Oncolytic Virus Revenue Market Share by Region (2016-2021)
Figure 17. Global Oncolytic Virus Revenue Market Share by Region in 2020
Figure 18. Global Oncolytic Virus Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Oncolytic Virus Revenue in 2020
Figure 20. Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Oncolytic Virus Sales Market Share by Type (2016-2021)
Figure 22. Global Oncolytic Virus Sales Market Share by Type in 2020
Figure 23. Global Oncolytic Virus Revenue Market Share by Type (2016-2021)
Figure 24. Global Oncolytic Virus Revenue Market Share by Type in 2020
Figure 25. Global Oncolytic Virus Sales Market Share by Application (2016-2021)
Figure 26. Global Oncolytic Virus Sales Market Share by Application in 2020
Figure 27. Global Oncolytic Virus Revenue Market Share by Application (2016-2021)
Figure 28. Global Oncolytic Virus Revenue Market Share by Application in 2020
Figure 29. China Oncolytic Virus Sales Growth Rate 2016-2027 (K Units)
Figure 30. China Oncolytic Virus Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Oncolytic Virus Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Oncolytic Virus Players Market Share by Revenue in Oncolytic Virus in 2020
Figure 33. China Oncolytic Virus Revenue Share by Type (2016-2021)
Figure 34. China Oncolytic Virus Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Oncolytic Virus Revenue Share by Application (2016-2021)
Figure 36. China Oncolytic Virus Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Oncolytic Virus Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Oncolytic Virus Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Oncolytic Virus Sales Market Share by Country in 2020
Figure 40. North America Oncolytic Virus Revenue Market Share by Country in 2020
Figure 41. U.S. Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Oncolytic Virus Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Oncolytic Virus Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Oncolytic Virus Sales Market Share by Country in 2020
Figure 48. Europe Oncolytic Virus Revenue Market Share by Country in 2020
Figure 49. Germany Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Oncolytic Virus Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Oncolytic Virus Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Oncolytic Virus Sales Market Share by Region in 2020
Figure 62. Asia Pacific Oncolytic Virus Revenue Market Share by Region in 2020
Figure 63. China Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 84. Vietnam Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Oncolytic Virus Sales Growth Rate 2016-2021 (K Units)
Figure 86. Latin America Oncolytic Virus Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Oncolytic Virus Sales Market Share by Country in 2020
Figure 88. Latin America Oncolytic Virus Revenue Market Share by Country in 2020
Figure 89. Mexico Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 90. Mexico Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 92. Brazil Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 94. Argentina Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Oncolytic Virus Sales Growth Rate 2016-2021 (K Units)
Figure 96. Middle East and Africa Oncolytic Virus Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Oncolytic Virus Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Oncolytic Virus Revenue Market Share by Country in 2020
Figure 99. Turkey Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 100. Turkey Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 102. Saudi Arabia Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Oncolytic Virus Sales Growth Rate (2016-2021) (K Units)
Figure 104. UAE Oncolytic Virus Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Oncolytic Virus Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
腫瘍溶解性ウイルスの世界市場 2020年 Market Overview The global Oncolytic Virus market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncolytic Virus market report…- ウイルスろ過の世界及び中国市場 Virus filtration (VF) is a key step in an overall viral clearance process since it has been demonstrated to effectively clear a wide range of mammalian viruses with a log reduction value (LRV) > 4. The potential to achieve higher LRV from virus retentive filters has historically been examined using …
- C型肝炎ウイルスエンベロープタンパク質E2の世界市場 2020年 Market Overview The global Hepatitis C Virus Envelope Protein E2 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Hepatit…
- ウイルスろ過の世界市場 2020年 Market Overview The Virus Filtration market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 呼吸器合胞体ウイルス付着糖タンパク質の世界市場 2020年 Market Overview The global Respiratory Syncytial Virus Attachment Glycoprotein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 201…